# Kleo Pharmaceuticals, Inc.: Form D filings

Kleo Pharmaceuticals, Inc., a pharmaceuticals company in New Haven, CT, filed 4 Form D notices with the SEC between 2017 and 2019. The latest, on January 15, 2019, reports $21.2 million sold of a $21.2 million offering to 19 investors.

Find out what Kleo Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Kleo%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Kleo%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fkleo-pharmaceuticals-inc-1700389)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Kleo%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Kleo%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fkleo-pharmaceuticals-inc-1700389)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut): 428 rows, by operating companies, filed since November 1, 2024, $21.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/connecticut
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 25 SCIENCE PARK, SUITE 2D, 150 MUNSON ST., New Haven, CT, 06511
- Phone: (203) 691-6332
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2015
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1700389

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 15, 2019 | New notice | $21,206,378 | $21,206,378 | $0 | 19 | Nov 12, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1700389/000094562119000016/0000945621-19-000016-index.htm) |
| May 29, 2018 | Amendment | Indefinite | $13,531,612 | Indefinite | 11 | Aug 29, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1700389/000170038918000001/0001700389-18-000001-index.htm) |
| May 26, 2017 | Amendment | Indefinite | $11,000,000 | Indefinite | 9 | Aug 29, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1700389/000170038917000002/0001700389-17-000002-index.htm) |
| May 23, 2017 | New notice | Indefinite | $19,403,470 | Indefinite | 23 | Feb 28, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1700389/000170038917000001/0001700389-17-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Douglas Manion | Executive Officer, Director |  |
| Charles G. Drake | Director |  |
| Declan Doogan | Director |  |
| Roy Prieb | Executive Officer, Director |  |
| Alexander Goor | Director |  |
| John W. Childs | Director |  |

## Other pharmaceuticals companies in Connecticut that filed recently

- [Thetis Pharmaceuticals LLC](https://specstream.ai/data/form-d/company/thetis-pharmaceuticals-llc-1528491) $560,300 · Oct 13, 2026
- [Inventure, LLC](https://specstream.ai/data/form-d/company/inventure-llc-1706556) $82,345 · Sep 3, 2026

[Every Form D from the week of Jan 14, 2019](https://specstream.ai/data/form-d/week/2019-01-14) · [All recent filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Kleo Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).